Paeds SAQs · clinical-pharmacology-and-therapeutics
Complementary, alternative and traditional medicines — formative SAQs
Two formative SAQs on complementary, alternative and traditional medicines in children: the five CAM domains and why most use is undisclosed, the four pathways to harm (heavy-metal contamination, herb-drug interactions, misidentification and dosing inconsistency, delay of conventional care), the bedside safety conversation, and the regional regulatory and evidence picture.
On this page
Study tools
Target exams
SAQ 1 — Classification, prevalence and the bedside safety conversation
Stem (20 marks; suggested 15 minutes): [1]
A four-year-old child of South Asian heritage presents with three weeks of abdominal pain, constipation and lethargy. The blood count shows a microcytic anaemia. On direct, non-judgemental questioning, the mother reveals the child has been taking an Ayurvedic preparation "for strength" for two months. Separately, the mother of a 10-year-old with epilepsy asks whether the St John's wort she has started giving him "for mood" is safe alongside his antiseizure medicines. [8] [5]
(a) Define complementary and alternative medicine (CAM), name the five CAM domains, and classify the two products above into the most relevant domain. (8 marks) [1]
(b) Outline the stepwise bedside safety conversation you would have with each family, and state why routine, non-judgemental asking is the single most important intervention. (8 marks) [4]
(c) For the first child, state the most likely diagnosis, the first-line investigation, and one immediate management step. (4 marks) [6]
Model answer — SAQ 1
(a) Definition, five domains and classification (8 marks). [1]
- Definition — CAM is a diverse group of health systems, practices and products not presently considered part of conventional biomedicine: complementary when used alongside conventional care, alternative when used instead of it, integrative when evidence-based CAM is combined with conventional care in a coordinated way. (2 marks)
- Five domains — (1) biologically based therapies (herbs, botanicals, vitamins, supplements); (2) mind-body medicine (meditation, yoga, hypnosis); (3) manipulative and body-based practices (massage, chiropractic, osteopathy); (4) energy therapies (Reiki, biofield); (5) whole medical systems (Ayurveda, traditional Chinese medicine, homeopathy, naturopathy, Indigenous healing). (5 marks)
- Classification — the Ayurvedic preparation is a whole medical system product (Ayurveda) and is the principal source of heavy-metal contamination; the St John's wort is a biologically based therapy (botanical) and is the principal source of herb-drug interactions. (1 mark) [1] [7]
(b) Bedside safety conversation (8 marks — the six steps, 1 mark each, capped at 8). [4]
- Ask respectfully and routinely — use open, normalised wording ("Lots of families give their children herbs, vitamins or traditional remedies — does your child take any?") rather than closed or judgemental questions. [4]
- Document every remedy — name, dose, frequency, route, source and recommender, in the same place as conventional medicines. [4]
- Screen for interactions and contamination — for the St John's wort, check against the antiseizure medicines for CYP3A4 interactions; for the Ayurvedic preparation, consider heavy-metal contamination. [5]
- Assess the evidence and the risk — is it directly harmful; is it substituting for proven care; is the child particularly vulnerable? [4]
- Counsel honestly and collaboratively — explain the assessment in plain language, respect the family's beliefs, use shared decision-making; do not dismiss CAM wholesale. [4]
- Coordinate and follow up — integrate agreed safe CAM, arrange follow-up, report adverse events. [4]
Routine, non-judgemental asking is the single most important intervention because non-disclosure is the default — a parent who fears disapproval will not volunteer CAM use, so the only way to surface the hidden pathways is to ask openly and routinely. (credit within step 1) [1]
(c) Diagnosis, investigation and immediate management (4 marks). [6]
- Most likely diagnosis — lead poisoning from a contaminated Ayurvedic preparation; the abdominal pain, constipation, lethargy and microcytic anaemia are the classic paediatric presentation. (1 mark) [8]
- First-line investigation — a venous blood lead level (with arsenic and mercury levels if the exposure history suggests them); basophilic stippling on the blood film supports the diagnosis. (2 marks) [6]
- Immediate management step — stop the Ayurvedic product and involve the toxicology service (chelation is guided by the blood level and specialist advice; supportive care is the backbone). Arrange for the product to be tested and notify public health. (1 mark) [8]
SAQ 2 — Herb-drug interactions, homeopathy and the regulatory picture
Stem (20 marks; suggested 15 minutes): [5]
A fellowship examiner asks: "Why does complementary and alternative medicine sometimes harm children, and how should clinicians and regulators respond?" [1] [4]
(a) Describe the four pathways by which CAM use harms children, giving a named example of each. (10 marks) [7]
(b) Summarise the evidence on homeopathic products for children, and describe the regulatory frameworks in the WHO, UK, Australia and the United States. (10 marks) [10]
References7ShowHide
- [1]Ernst E Prevalence of complementary/alternative medicine for children: a systematic review. Eur J Pediatr, 1999.PMID 9950300
- [4]Gilmour J, Harrison C, Asadi L et al. Informed consent: advising patients and parents about complementary and alternative medicine therapies. Pediatrics, 2011.PMID 22045862
- [5]Feucht C, Patel DR Herbal medicines in pediatric neuropsychiatry. Pediatr Clin North Am, 2011.PMID 21281847
- [6]McRae A, Vilcins D, Le HHTC et al. Lead in traditional and complementary medicine: a systematic review. Rev Environ Health, 2024.PMID 36322973
- [7]Ernst E Heavy metals in traditional Indian remedies. Eur J Clin Pharmacol, 2002.PMID 11936709
- [8]Datta-Mitra A, Ahmed O Jr Ayurvedic medicine use and lead poisoning in a child: a continued concern in the United States. Clin Pediatr (Phila), 2015.PMID 25305259
- [10]Hawke K, King D, van Driel ML et al. Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children. Cochrane Database Syst Rev, 2022.PMID 36511520